Abstract
The majority of active duty service women (ADS) are young, have access to healthcare, and meet fitness standards set by the U.S. military, suggesting that ADS represent a healthy population at low risk of cancer. Breast cancer is, however, the most common cancer in ADS and may have a significant effect on troop readiness with lengthy absence during treatment and inability to return to duty after the treatment. The identification of unaffected ADS who carry germline mutations in cancer predisposition genes ("previvors") would provide the opportunity to prevent or detect cancer at an early stage, thus minimizing effects on troop readiness. In this study, we determined (1) how many high-risk ADS without cancer pursued genetic testing, (2) how many previvors employed risk-reducing strategies, and (3) the number of undiagnosed previvors within an ADS population. The Clinical Breast Care Project (protocol WRNMMC IRB #20704) database of the Murtha Cancer Center/Walter Reed National Military Medical Center was queried to identify all ADS with no current or previous history of cancer. Classification as high genetic risk was calculated using National Comprehensive Cancer Network 2019 guidelines for genetic testing for breast, ovary, colo...Continue Reading
References
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J NixonJ R Harris
Oct 22, 2004·Military Medicine·Anuli AjeneDavid M Sack
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Mar 26, 2009·Journal of the American College of Surgeons·Jennifer L GnerlichJulie A Margenthaler
Jun 10, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kangmin ZhuKatherine A McGlynn
Sep 3, 2010·JAMA : the Journal of the American Medical Association·Susan M DomchekTimothy R Rebbeck
Feb 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen H LuUNKNOWN American Society of Clinical Oncology
Sep 10, 2014·JAMA : the Journal of the American Medical Association·Mary-Claire KingAmnon Lahad
Oct 15, 2014·Breast Cancer Research and Treatment·Xinglei ChaiTimothy R Rebbeck
Mar 15, 2015·Medical Care·Sarah ColonnaCarol Sweeney
Aug 14, 2015·JAMA Oncology·Andrea DesmondLeif W Ellisen
Dec 3, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Elvira D'AndreaPaolo Villari
Apr 17, 2018·Military Medicine·Yvonne L EaglehouseKangmin Zhu
Sep 22, 2018·Oncotarget·Ranjit Manchanda, Rosa Legood
Dec 24, 2018·Cancers·Joanne Kotsopoulos
Feb 13, 2019·Journal of the National Cancer Institute·Sarah KnerrKaren J Wernli
Apr 12, 2019·British Journal of Cancer·Kelly MetcalfeUNKNOWN Hereditary Breast Cancer Clinical Study Group
Nov 5, 2019·Cancer·Valentina VysotskaiaKatherine Johansen Taber
Dec 23, 2019·The Breast Journal·Marie E WoodIsabelle Bedrosian
May 20, 2020·International Journal of Technology Assessment in Health Care·Manjusha HurryPaul Hoskins